Aliskiren/amlodipine/hydrochlorothiazide
Combination of | |
---|---|
Aliskiren | Renin inhibitor |
Amlodipine | Calcium channel blocker |
Hydrochlorothiazide | Diuretic |
Clinical data | |
AHFS/Drugs.com | Consumer Drug Information |
Licence data | |
Pregnancy category |
|
Routes of administration | Oral |
Legal status |
|
Identifiers | |
CAS Number | 1486517-17-2 |
ATC code | C09XA54 |
(verify) |
The drug combination aliskiren/amlodipine/hydrochlorothiazide (INNs, trade name Amturnide) is an antihypertensive approved by the U.S. Food and Drug Administration (FDA) on December 21, 2010.[1]
References
External links
|
|
This article is issued from Wikipedia - version of the Monday, February 15, 2016. The text is available under the Creative Commons Attribution/Share Alike but additional terms may apply for the media files.